Stock Chart

KRRO

$13.33 +0.15%
Score: 53.3 HOLD
LEAPs: SELL $15
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $15
Premium: $3.70
Expiry: Dec 18, 2026
Target: $12
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $13.33 - $18.05 STRONG_DOWNTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.65
Vol: 1.29x (vs SPY: 1.0x | vs QQQ: 1.0x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About KRRO - Korro Bio, Inc. Common Stock

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering …

Key Statistics

Market Cap $126M

This KRRO stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track KRRO's price movements with trendlines, gamma walls, and key support/resistance levels.